[Recent advance in tuberous sclerosis-related genes and their expression].
Liu
Jing
J
Piao
Yue-shan
YS
Lu
De-hong
DH
D000230:Adenocarcinoma / Q000235:genetics / Q000378:metabolism; D018207:Angiomyolipoma / Q000209:etiology; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D001254:Astrocytoma / Q000209:etiology; D001932:Brain Neoplasms / Q000209:etiology; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D016147:Genes, Tumor Suppressor; D006801:Humans; D007680:Kidney Neoplasms / Q000209:etiology; D008175:Lung Neoplasms / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D020123:Sirolimus / Q000627:therapeutic use; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D014402:Tuberous Sclerosis / Q000150:complications / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism*
D000903:Antibiotics, Antineoplastic; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus